HEPATITIS C

This study tested whether adding an experimental drug called MP-424 to the standard two-drug treatment could help patients with a difficult-to-treat form of Hepatitis C who had not responded to prior therapy. It involved 32 adults with chronic Hepatitis C (Genotype 1) and measure…

This study tested whether a drug called MP-424 could help people with a specific type of chronic hepatitis C. Fifteen patients with genotype 1b hepatitis C who hadn't taken certain other medications received the treatment. Researchers checked if the virus remained undetectable si…

This study tested whether a combination of two oral drugs, bemnifosbuvir and ruzasvir, could safely and effectively treat chronic hepatitis C virus (HCV) infection. It involved 275 adults with HCV who had never taken this type of antiviral medication before. The main goal was to …

This completed Phase 3 trial tested whether adding an experimental drug (MP-424) to two standard hepatitis C medications could better control the virus. It involved 189 adults with a specific strain of hepatitis C who had never received treatment before. The main goal was to see …

This early-stage study tested the safety of a new drug called MP-424 when given alongside two standard hepatitis C medications. It involved 20 patients with a specific type of chronic hepatitis C. The main goal was to see how the body processes the new drug and to check for any s…

This study tested a new support program designed to help people with HIV, hepatitis C, or substance use disorders get medical care after they are released from prison. Researchers worked with 219 men and women before their release to see if the program was practical and acceptabl…

This study tested whether a smartphone app called GeoPassport, combined with peer mentor support and small rewards, could help men and transgender women leaving jail access important health services. The goal was to see if this approach helped people get HIV prevention medication…

This research study aims to identify human proteins that stick to hepatitis C virus particles in blood samples. Researchers want to understand how these human proteins help the virus infect cells and multiply. The findings could reveal new targets for future hepatitis C treatment…

This study aimed to learn more about Hepatitis C virus (HCV) infection by observing people who tested positive for it while donating blood. Researchers followed 805 participants over time to understand how the virus spreads, who develops liver problems, and how infectious people …

This study aimed to find out how many people held in a specific French detention center had HIV, hepatitis B, or hepatitis C. Researchers used rapid tests to screen 350 detainees, as many come from regions where these infections are common and may not know their status. The goal …